查看完整行情页>>

|

货币单位:美元(USD)

阿斯利康公司

AstraZeneca Plc (azn)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
Sherilyn S. McCoy Sherilyn S. McCoy is an American businessperson who has been at the helm of 6 different companies. Presently, she holds the position of Chairman for Certara, Inc., Chairman of Certara USA, Inc. and Non-Executive Chairman at Aldevron LLC. She is also Member-President Business Leaders Cabinet at Rutgers State University of New Jersey and on the board of 9 other companies. In the past Ms. McCoy held the position of Vice Chairman-Executive Committee at Johnson & Johnson Global President-Baby & Wound Care Franchise at McNeil-PPC, Inc. and Chairman-Worldwide Franchise at Ethicon, Inc. (both are subsidiaries of Johnson & Johnson), Chief Executive Officer & Director at Avon Products, Inc. and Co-Chairman at US Foundation for Inspiration & Recognition of Science & Tech. Sherilyn S. McCoy received an undergraduate degree from the University of Massachusetts, a graduate degree from Princeton University and an MBA from Rutgers State University of New Jersey.
Pam P. Cheng Currently, Pam P. Cheng holds the position of Executive VP-Operations & Information Technology at AstraZeneca Plc. She is also on the board of Codexis, Inc. and Smiths Group Plc. In the past she held the position of Senior VP-Global Supply Chain Management at Merck & Co., Inc. and President for MSD China Holding Co., Ltd. (a subsidiary of Merck & Co., Inc.). Pam P. Cheng received an MBA from Pace University and a graduate degree and an undergraduate degree from Stevens Institute of Technology.
Leif Valdemar Johansson Leif Valdemar Johansson is a Swedish businessperson who has been the head of 11 different companies. Presently, Mr. Johansson holds the position of Non-Executive Chairman at AstraZeneca Plc. He is also on the board of Autoliv, Inc., Boao Forum For Asia, Ecolean AB and Föreningen Teknikföretagen i Sverige. In his past career he held the position of Chairman at Telefonaktiebolaget LM Ericsson and Chairman of Ericsson Danmark A (a subsidiary of Telefonaktiebolaget LM Ericsson), Chairman at European Automobile Manufacturers Association, Chairman at European Round Table of Industrialists, Chairman at Ericsson AB, Chief Executive Officer for Electrolux AB, President & Chief Executive Officer for Volvo AB, Chairman of Volvo Aero Corp., Chief Executive Officer for Volvo Flygmotor AB and Chairman of Royal Swedish Academy of Engineering Sciences. He received a graduate degree from Chalmers University of Technology.
Philip Arthur John Broadley Founder of The European Insurance CFO Forum, Philip Arthur John Broadley currently is Treasurer of The London Library. He is also on the board of AstraZeneca Plc, Legal & General Group Plc and BrightSphere, Inc. and Chairman-Trustees Board at Eastbourne College and Member-Code Committee at The Takeover Panel. Mr. Broadley previously occupied the position of Chairman of The Hundred Group of Finance Directors, Chairman at The 100 Group, Trustee & Founding Member at The European Insurance CFO Forum, Group Finance Director at Prudential Plc, Member-Insurance Working Group at International Accounting Standards Board, Group Finance Director & Executive Director at OM Residual UK Ltd. and Partner at Arthur Andersen (UK). Mr. Broadley received an undergraduate degree from St. Edmund Hall Association and a graduate degree from London School of Economics & Political Science.
Rudolph Harold Peter Markham Rudolph Harold Peter Markham is on the board of United Parcel Service, Inc. and 4 other companies. In the past he held the position of Non-Executive Director at Legal & General Group Plc, Non-Executive Chairman for Moorfields Eye Hospital NHS Foundation Trust, Chief Finance Officer & Executive Director at Unilever NV and Chairman & Chief Executive Officer at Unilever Japan KK (a subsidiary of Unilever NV) and Chief Financial Officer & Executive Vice President for Unilever Plc and Chairman at Unilever Australia (Holdings) Pty Ltd. (a subsidiary of Unilever Plc). Mr. Markham received a graduate degree from Christ's College.
Kevin G. Lokay Kevin G. Lokay is on the board of Galera Therapeutics, Inc. and Head-U.S. Lung Cancer Franchise at AstraZeneca Plc. In the past Mr. Lokay was President & Chief Executive Officer at Jazz Pharmaceuticals (EUSA Pharma USA), Inc. and Vice President & Head-Business Unit at Boehringer Ingelheim Corp. Kevin G. Lokay received an MBA from Purdue University and an undergraduate degree from Lafayette College.
Marcus Wallenberg Mr. Marcus Wallenberg is Vice Chairman at Investor AB, Chairman at Saab AB, Chairman at Saab Systems Pty Ltd., Chairman at Skandinaviska Enskilda Banken AB, Chariman at Patricia Industries, Inc. and Vice Chairman & Treasurer at The Institute of International Finance, Inc. He is on the Board of Directors at Investor AB, Temasek Holdings (Pte) Ltd., AstraZeneca Plc, Patricia Industries AB, Knut och Alice Wallenbergs Stiftelse and The Institute of International Finance, Inc. Prior to joining Patricia Industries, Mr. Wallenberg was employed as Chairman atLuossavaara-Kiirunavaara AB, a Managing Director at Investor AB (Investment Company), Chairman by Electrolux AB, Chairman by Skandinaviska Enskilda Banken AB, an Independent Director at Stora Enso Oyj, Deputy Chairman by LM Ericsson Telefon AB, Chairman by International Chamber of Commerce Sweden, and Vice Chairman by Telefonaktiebolaget LM Ericsson /Mobitex Wireless Data Div/. He also served on the board at Astra AB, Citibank NA, Cititrust Ltd. (Hong Kong), Deutsche Bank AG, EQT Holdings AB, S G Warburg Co. Ltd., SCANIA AB, Stockholm Holdings Ltd. and Stora Feldmühle. Mr. Wallenberg received his undergraduate degree from Royal Swedish Marine Academy.
Graham Andrew Chipchase Graham Andrew Chipchase occupies the position of Chief Executive Officer & Director at Brambles Ltd. Mr. Chipchase is also on the board of AstraZeneca Plc. In his past career Mr. Chipchase was Chief Executive Officer & Executive Director at Rexam Ltd., Finance Director for GKN Ltd. and Director-Planning & Financial Control at BOC Group, Inc. He received a graduate degree from Oriel College.
Marc Pierre Jean Dunoyer Marc Pierre Jean Dunoyer is Chief Financial Officer & Executive Director at AstraZeneca Plc and on the board of 5 other companies. In the past he occupied the position of Global Head-Rare Diseases Unit at GlaxoSmithKline Plc and Chairman of GlaxoSmithKline KK (a subsidiary of GlaxoSmithKline Plc) and President-Asia Pacific at Hoechst Marion Roussel SA. Mr. Dunoyer received an MBA from Hautes Etudes Commerciales and a graduate degree from University Paris-Sorbonne (Paris IV).
Michel Demaré Mr. Michel Demaré is an Independent Non-Executive Director at AstraZeneca Plc and a Member at Beirat Zukunft Finanzplatz. He is on the Board of Directors at AstraZeneca Plc, Vodafone Group Plc, Louis Dreyfus Company Holdings BV and International Institute for Management Development. Mr. Demaré was previously employed as a Chairman by SwissHoldings, a Chairman by Syngenta Foundation For Sustainable Agriculture, a Vice Chairman-Supervisory Board by Syngenta AG, an Independent Vice Chairman by UBS Group AG, a Vice Chairman-Supervisory Board by UBS AG, a Chief Financial Officer by ABB Ltd., a Chief Financial Officer-Europe Region by Baxter International, Inc., and a CFO-Global Polyolefins & Elastomers Division by The Dow Chemical Co.(Delaware). He received his undergraduate degree from Université Catholique de Louvain and an MBA from Katholieke Universiteit Leuven.
Adrian Charles Noel Kemp Adrian Charles Noel Kemp is Secretary at AstraZeneca Plc. Mr. Kemp is also on the board of 7 other companies. Mr. Kemp previously was General Counsel of MedImmune Ltd. He received an undergraduate degree from the University of Birmingham.
Geneviéve B. Berger Presently, Geneviéve B. Berger is Chief Research Officer at Firmenich SA. Dr. Berger is also on the board of AstraZeneca Plc and Air Liquide SA. In the past Dr. Berger occupied the position of Chief Executive Officer for Centre National de la Recherche Scientifique, Chief Science Officer at Unilever NV and Chief Research & Development Officer at Unilever France SAS (a subsidiary of Unilever NV), Chief Scientific Officer for Unilever Plc, Professor at Assistance Publique des Hôpitaux de Paris SA, Professor at Groupe hospitalier Pitié-Salpêtrière, Technology Director at France Ministry of National Education, Higher Educ & Research, Head-Biosphysics & Nuclear Medicine at Religious Hospitallers of Saint Joseph of The Hotel Dieu of, Professor at Université Pierre et Marie Curie and Professor at Université Paris 1. Dr. Berger received an undergraduate degree from École normale supérieure de Cachan, a doctorate from the University of Paris V, a doctorate from Université Pierre et Marie Curie and a doctorate from the University of Paris V.
José Baselga José Baselga is an entrepreneur who founded Venthera, Inc., Mosaic Biomedicals SL and Tango Therapeutics, Inc. He is on the board of Breast International Group and Foghorn Therapeutics, Inc. and Executive VP-Oncology Research & Development at AstraZeneca Plc, Member of Association of American Physicians, Member of American Society of Clinical Investigation and Member of Institute of Medicine. In his past career Dr. Baselga was President for American Association for Cancer Research, Associate Director at Massachusetts General Hospital Cancer Center, Chairman-Hematology & Oncology Division at The General Hospital Corp., President of European Society for Medical Oncology, Chief Medical Officer at Memorial Sloan-Kettering Cancer Center, Director at American Society of Clinical Oncology, Professor at Weill Cornell Medical College, Professor at Harvard Medical School, Director & Chairman-Medical Oncology Service at Vall d'Hebron Institut d'Oncologia and Member of National Academy of Medicine of United States. José Baselga received a doctorate from Autonomous University of Barcelona.
Pascal Soriot Presently, Pascal Soriot holds the position of Chief Executive Officer & Executive Director at AstraZeneca Plc and Chairman for AstraZeneca AB (a subsidiary of AstraZeneca Plc). He is also on the board of CSL Ltd., Pharmaceutical Research & Manufacturers of America and Acerta Pharma BV. In the past Dr. Soriot held the position of Manager-District Sales at Roussel NZ Ltd., Director & Chief Executive Officer-Roche Group at Genentech, Inc., Chief Operating Officer of Roche Pharmaceuticals, Inc., Chief Operating Officer at Sanofi-Aventis U.S. LLC and Vice President-Asia Pacific at Hoechst Marion Rousel JP. He received an MBA from École des Hautes Études Commerciales de Paris and a doctorate from École Nationale Vétérinaire d'Alfort.
Colin Reisner Colin Reisner is Member of American Thoracic Society, Inc. and Head-Clinical Respiratory at AstraZeneca Plc. In his past career he held the position of Senior Director-Respiratory Division at GlaxoSmithKline, Inc., Principal at Boehringer Ingelheim Corp., Executive Director-Global Respiratory Development at Novartis Corp., Assistant Consulting Professor at Duke University and Assistant Consulting Professor at Yale University. Dr. Reisner received an undergraduate degree from the University of the Witwatersrand.
Jeffrey Pott Jeffrey Pott occupies the position of General Counsel for AstraZeneca Plc. In the past he occupied the position of Chairman at Aptium Oncology, Inc. and Principal at Drinker Biddle & Reath LLP. Mr. Pott received an undergraduate degree from Wheaton College (Illinois) and a graduate degree from Villanova University School of Law.
Menelas N. Pangalos Menelas N. Pangalos is EVP-Biopharmaceuticals Research & Development at AstraZeneca Plc, Member of British Pharmacological Society and Member of Society For Neuroscience and on the board of 5 other companies. In the past he occupied the position of Chief Scientific Officer & Senior Vice President at Neuroscience Research Australia. He received an undergraduate degree from Imperial College London and a doctorate from the University of London.
Katarina Ageborg Currently, Katarina Ageborg is Chief Compliance Officer & EVP-Sustainability at AstraZeneca Plc. In the past she was President at AstraZeneca AB. Ms. Ageborg received a graduate degree from the University of Uppsala.
Thomas Kudsk Larsen Presently, Thomas Kudsk Larsen holds the position of Investor Relations Contact at AstraZeneca Plc and Head-Investor Relations North America at Roche Holdings, Inc.
Diana Layfield Diana Layfield is on the board of AstraZeneca Plc and Aggreko Plc and Vice President-Payments & Commerce at Google LLC. In her past career she occupied the position of Chief Executive Officer at Finexia Ltd. and Chief Executive Officer-African Region at Standard Chartered Plc. She received an undergraduate degree from the University of Oxford and a graduate degree from Harvard University.
Deborah DiSanzo Deborah DiSanzo is on the board of AstraZeneca Plc, Novanta, Inc. and Project HOPE-The-People-To-People HealthFoundation, Inc. In her past career she occupied the position of Executive Vice President at Koninklijke Philips NV and Chief Executive Officer of Philips Healthcare (a subsidiary of Koninklijke Philips NV) and General Manager-IBM Watson Health at International Business Machines Corp. Deborah DiSanzo received an MBA from Babson College and an undergraduate degree from Merrimack College.
Ruud Dobber Ruud Dobber is Executive VP-Biopharmaceuticals Business at AstraZeneca Plc. In his past career he occupied the position of Chairman-Asia division at Pharmaceutical Research & Manufacturers of America. He received a doctorate from the University of Leiden.
Euan A. Ashley Euan A. Ashley is the founder of Personalis, Inc. He is on the board of AstraZeneca Plc.
Fiona Cicconi Presently, Fiona Cicconi is Executive Vice President-Human Resources at AstraZeneca Plc.
Tyrell J. Rivers Tyrell J. Rivers is Executive Director-Corporate Development at AstraZeneca Plc and on the board of 5 other companies. In the past Dr. Rivers was Senior Associate at MedImmune Ventures, Inc. He received an undergraduate degree from Massachusetts Institute of Technology, a doctorate and a graduate degree from The University of Texas and an MBA from The Leonard N Stern School of Business.
Nazneen Rahman Nazneen Rahman founded Tglclinical Genetic Testing Laboratory. Dr. Rahman is on the board of AstraZeneca Plc. Dr. Rahman previously was Head-Genetics & Epidemiology Division at The Institute of Cancer Research: Royal Cancer Hospital, Head-Cancer Genetics at Royal Marsden NHS Foundation Trust and Director at Tglclinical Genetic Testing Laboratory. Dr. Rahman received a doctorate from the University of Oxford.
David Fredrickson David Fredrickson is EVP & Global Head-Oncology Business Unit at AstraZeneca Plc. He previously occupied the position of President at AstraZeneca KK, Vice President-Specialty Care at AstraZeneca LP and Manager-Business Unit at Genentech, Inc. He received an undergraduate degree from Georgetown University.
Jonathan Thomas Charles Slade Jonathan Thomas Charles Slade holds the position of Group Treasurer at AstraZeneca Plc. Mr. Slade is also on the board of AstraZeneca Treasury Ltd., Astrazeneca Sweden Investments Ltd., AstraZeneca US Investments Ltd. and AstraZeneca Intermediate Holdings Ltd.
Tony Mok Founder of Chinese Thoracic Oncology Group, Sanomics Ltd. and Asia Thoracic Oncology Research Group, Tony Mok is a Canadian entrepreneur who is Chairman at Sanomics Ltd. and Secretary at Chinese Society of Clinical Oncology. He is also on the board of AstraZeneca Plc, Hutchison China MediTech Ltd. and American Society of Clinical Oncology and Treasurer of International Association for the Study of Lung Cancer. In his past career he occupied the position of Chairman-Clinical Oncology Department at The Chinese University of Hong Kong. Tony Mok received an undergraduate degree and a doctorate from the University of Alberta.
Helen MacPhee Helen MacPhee is on the board of H+H International An and Primary Science Teaching Trust and Vice President of AstraZeneca Plc.
Sjoerd Hubben Presently, Sjoerd Hubben is Vice President-Global Government Affairs & Policy at AstraZeneca Plc.
Iskra Reic Iskra Reic is Executive Vice President-Europe & Canada at AstraZeneca Plc.
Elisabeth Björk Ms. Elisabeth Björk is an Independent Director at Rocket Pharmaceuticals, Inc. and a Senior Vice President at AstraZeneca Plc. She is on the Board of Directors at Rocket Pharmaceuticals, Inc. and Björks Matematik o Mera AB.
Henry D. Cremisi Currently, Henry D. Cremisi occupies the position of Medical Director for AstraZeneca Plc. Dr. Cremisi is also on the board of Daxor Corp. and Member of American Society of Nephrology, Member of Renal Physicians Association, Member of Society of Hospital Medicine, Member of Heart Failure Society of America, Inc., Member of American College of Physicians, Member of Cardio Renal Society of America and Member of American Medical Association.